{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:37:50Z","timestamp":1786991870091,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["F31 DE027586"],"award-info":[{"award-number":["F31 DE027586"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA056452"],"award-info":[{"award-number":["CA056452"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA101642"],"award-info":[{"award-number":["CA101642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41 EB023833"],"award-info":[{"award-number":["P41 EB023833"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jconrel.2021.10.008","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T02:49:58Z","timestamp":1634093398000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications"],"prefix":"10.1016","volume":"339","author":[{"given":"Brenda","family":"Melendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Dottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayla","family":"Borthwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie E.","family":"Schmandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleah","family":"Cumpian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Celestino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Fellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios G.","family":"Mikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda S.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.10.008_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978\u20132013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0015","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0020","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine cancer incidence and mortality - United States, 1999\u20132016","volume":"67","author":"Henley","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/AOG.0000000000000381","article-title":"Obesity and age at diagnosis of endometrial cancer","volume":"124","author":"Nevadunsky","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0035","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-43139-0_1","article-title":"Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences","author":"Felix","year":"2017"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jmig.2017.07.022","article-title":"Updates on conservative management of endometrial cancer","volume":"25","author":"Corzo","year":"2018","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0055","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0060","first-page":"691","article-title":"Preserving fertility in young patients with endometrial cancer: current perspectives","volume":"6","author":"Kalogera","year":"2014","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2013.11.018","article-title":"The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter?","volume":"132","author":"Smits","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/gyn.2015.0114","article-title":"The impact of obesity on surgical outcome in endometrial cancer patients: a systematic review","volume":"32","author":"Orekoya","year":"2016","journal-title":"J. Gynecol. Surg."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2015.09.020","article-title":"The impact of BMI on surgical complications and outcomes in endometrial cancer surgery-an institutional study and systematic review of the literature","volume":"139","author":"Bouwman","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0080","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.ejca.2012.03.013","article-title":"Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: results from a randomised controlled trial","volume":"48","author":"Kondalsamy-Chennakesavan","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40661-016-0023-8","article-title":"Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy","volume":"3","author":"Obermair","year":"2016","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1242998","article-title":"Role of progesterone in endometrial cancer","volume":"28","author":"Kim","year":"2010","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0095","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000011965","article-title":"Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: a Hellenic cooperative oncology group study","volume":"56","author":"Bafaloukos","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0110","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","article-title":"Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the gynecologic oncology group","volume":"17","author":"Thigpen","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0115","series-title":"Mirena Full Prescribing Information","author":"B.H.P. Inc","year":"2017"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0130","series-title":"Endometrial Cancer: New Biology Driving Research and Treatment","article-title":"Long\u2013term follow\u2013up for a prospective phase II trial of levonorgestrel intrauterine device as non\u2013surgical treatment for complex atypical hyperplasia and early endometrial cancer","author":"Waters","year":"2020"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0140","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjc.6605109","article-title":"The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas","volume":"101","author":"Shoji","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajog.2006.10.872","article-title":"Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model","volume":"196","author":"Milam","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0160","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI41680","article-title":"Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer","volume":"120","author":"Miller","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/bcr3039","article-title":"Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer","volume":"13","author":"Miller","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0170","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdm170","article-title":"Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling","volume":"18","author":"Beeram","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0175","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1038\/onc.2015.414","article-title":"mTORC1 directly phosphorylates and activates ERalpha upon estrogen stimulation","volume":"35","author":"Alayev","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0180","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1074\/jbc.M807532200","article-title":"S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation","volume":"284","author":"Yamnik","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0185","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1002\/cncr.25515","article-title":"A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma","volume":"116","author":"Slomovitz","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1200\/JCO.2014.58.3401","article-title":"Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma","volume":"33","author":"Slomovitz","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0195","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/ijgc-00009577-200407000-00013","article-title":"The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers-a study of the National Cancer Institute of Canada Clinical Trials Group","volume":"14","author":"Ma","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0200","first-page":"393","article-title":"Everolimus-eluting stents in interventional cardiology","volume":"8","author":"Townsend","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/13625180903203154","article-title":"User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey","volume":"14","author":"Romer","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5468\/ogs.19169","article-title":"Fertility-sparing treatment in early endometrial cancer: current state and future strategies","volume":"63","author":"Obermair","year":"2020","journal-title":"Obstet Gynecol. Sci."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0220","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nprot.2009.24","article-title":"Synthesis of poly(propylene fumarate)","volume":"4","author":"Kasper","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0225","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jbm.820291011","article-title":"Analysis of a vinyl pyrrolidone\/poly(propylene fumarate) resorbable bone cement","volume":"29","author":"Gresser","year":"1995","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4636(199807)41:1<1::AID-JBM1>3.0.CO;2-N","article-title":"In vivo degradation of a poly(propylene fumarate)\/beta-tricalcium phosphate injectable composite scaffold","volume":"41","author":"Peter","year":"1998","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0235","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbm.a.31942","article-title":"Biodegradable fumarate-based drug-delivery systems for ophthalmic applications","volume":"88","author":"Hacker","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0240","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/jbm.a.34157","article-title":"Development of a biodegradable bone cement for craniofacial applications","volume":"100","author":"Henslee","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.05.024","article-title":"Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers","volume":"114","author":"Haesslein","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jbm.a.30080","article-title":"Development of biodegradable poly(propylene fumarate)\/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation","volume":"70","author":"Kempen","year":"2004","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1163\/156856208X393491","article-title":"Matrix modifications modulate ophthalmic drug delivery from photo-cross-linked poly(propylene fumarate)-based networks","volume":"20","author":"Haesslein","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpba.2012.05.038","article-title":"UV-visible spectroscopy as an alternative to liquid chromatography for determination of everolimus in surfactant-containing dissolution media: a useful approach based on solid-phase extraction","volume":"70","author":"Kamberi","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/chromsci\/46.1.23","article-title":"A sensitive high-throughput HPLC assay for simultaneous determination of everolimus and clobetasol propionate","volume":"46","author":"Kamberi","year":"2008","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/jrf.0.0740295","article-title":"The role of uterine luminal fluid in uterine contractions, sperm transport and fertility of rats","volume":"74","author":"Toner","year":"1985","journal-title":"Reproduction"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0275","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1200\/JCO.2007.14.1127","article-title":"Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data","volume":"26","author":"Tanaka","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0280","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/0008-5472.CAN-3554-2","article-title":"Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells","volume":"64","author":"Boulay","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0285","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.5012\/bkcs.2014.35.7.1939","article-title":"Preparation of solid dispersion of Everolimus in Gelucire 50\/13 using melt granulation technique for enhanced drug release","volume":"35","author":"Jang","year":"2014","journal-title":"B Korean Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2014.06.006","article-title":"Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique","volume":"473","author":"Jang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0295","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/jrf.0.0950551","article-title":"Increase in uterine peroxidase activity in the rat uterus during oestrogen hyperaemia","volume":"95","author":"Farley","year":"1992","journal-title":"J. Reprod. Fertil."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.10.008_bb0305","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1095\/biolreprod.109.076117","article-title":"Estrogen rapidly activates the PI3K\/AKT pathway and hypoxia\u2013inducible factor 1 and induces vascular endothelial growth factor a expression in luminal epithelial cells of the rat uterus","volume":"81","author":"Kazi","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0310","doi-asserted-by":"crossref","first-page":"15847","DOI":"10.1073\/pnas.0705749104","article-title":"Estradiol-17beta regulates mouse uterine epithelial cell proliferation through insulin-like growth factor 1 signaling","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0315","first-page":"E1382","article-title":"Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17beta is mediated by a PKC-ERK1\/2-mTOR signaling pathway","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0320","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1095\/biolreprod47.3.408","article-title":"The effect of estrogen and progesterone on structural changes in the uterine glandular epithelium of the ovariectomized sheep","volume":"47","author":"Murray","year":"1992","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jconrel.2021.10.008_bb0325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1095\/biolreprod.114.120170","article-title":"Uterine epithelial cell estrogen receptor alpha-dependent and -independent genomic profiles that underlie estrogen responses in mice","volume":"91","author":"Winuthayanon","year":"2014","journal-title":"Biol. Reprod."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592100537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592100537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:23:21Z","timestamp":1778300601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592100537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":65,"alternative-id":["S016836592100537X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}